416 related articles for article (PubMed ID: 33198323)
41. Kallikrein-related peptidases and associated microRNAs as promising prognostic biomarkers in gastrointestinal malignancies.
Adamopoulos PG; Tsiakanikas P; Scorilas A
Biol Chem; 2018 Jul; 399(8):821-836. PubMed ID: 29883317
[TBL] [Abstract][Full Text] [Related]
42. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
Kimhofer T; Fye H; Taylor-Robinson S; Thursz M; Holmes E
Br J Cancer; 2015 Mar; 112(7):1141-56. PubMed ID: 25826224
[TBL] [Abstract][Full Text] [Related]
43.
Pirro M; Mohammed Y; van Vliet SJ; Rombouts Y; Sciacca A; de Ru AH; Janssen GMC; Tjokrodirijo RTN; Wuhrer M; van Veelen PA; Hensbergen PJ
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752259
[TBL] [Abstract][Full Text] [Related]
44. Mass spectrometry based glycoproteomics--from a proteomics perspective.
Pan S; Chen R; Aebersold R; Brentnall TA
Mol Cell Proteomics; 2011 Jan; 10(1):R110.003251. PubMed ID: 20736408
[TBL] [Abstract][Full Text] [Related]
45. Advances in mass spectrometry driven O-glycoproteomics.
Levery SB; Steentoft C; Halim A; Narimatsu Y; Clausen H; Vakhrushev SY
Biochim Biophys Acta; 2015 Jan; 1850(1):33-42. PubMed ID: 25284204
[TBL] [Abstract][Full Text] [Related]
46. [Tumor cells transfer between the patient and laboratory animal as a basic methodological approach to the study of cancerogenesis and identification of biomarkers].
Klos D; Stašek M; Loveček M; Skalický P; Vrba R; Aujeský R; Havlík R; Neoral Č; Varanashi L; Hajdúch M; Vrbková J; Džubák P
Rozhl Chir; 2016; 95(12):432-438. PubMed ID: 28182438
[TBL] [Abstract][Full Text] [Related]
47. Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting.
Gholami S; Abidalhassan M; Cho M; Saeed A; Rocha FG
J Gastrointest Cancer; 2023 Jun; 54(2):672-676. PubMed ID: 35856132
[TBL] [Abstract][Full Text] [Related]
48. Pancreatic cancer: diagnosis and treatments.
Li HY; Cui ZM; Chen J; Guo XZ; Li YY
Tumour Biol; 2015 Mar; 36(3):1375-84. PubMed ID: 25680410
[TBL] [Abstract][Full Text] [Related]
49. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
50. Biomarkers for the early diagnosis of hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
[TBL] [Abstract][Full Text] [Related]
51. Caveolin-1 protein expression as a prognostic biomarker of gastrointestinal tumours: A systematic review and meta-analysis.
Kamposioras K; Dinas PC; Barriuoso J; Trachana V; Dimas K
Eur J Clin Invest; 2023 Dec; 53(12):e14065. PubMed ID: 37497737
[TBL] [Abstract][Full Text] [Related]
52. [Biomarkers for neoplasmas in digestive organs].
Iwasaki Y; Arai K; Katayanagi S; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1015-20. PubMed ID: 15272578
[TBL] [Abstract][Full Text] [Related]
53. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: mechanistic and clinical aspects.
Kontos CK; Mavridis K; Talieri M; Scorilas A
Thromb Haemost; 2013 Sep; 110(3):450-7. PubMed ID: 23446315
[TBL] [Abstract][Full Text] [Related]
54. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
Masuda T; Miyoshi E
Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856
[TBL] [Abstract][Full Text] [Related]
55. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
[TBL] [Abstract][Full Text] [Related]
56. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
57. Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia.
Baldus SE; Hanisch FG
Adv Cancer Res; 2000; 79():201-48. PubMed ID: 10818682
[No Abstract] [Full Text] [Related]
58. SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours.
López-Sánchez LM; Jiménez-Izquierdo R; Peñarando J; Mena R; Guil-Luna S; Toledano M; Conde F; Villar C; Díaz C; Ortea I; De la Haba-Rodríguez JR; Aranda E; Rodríguez-Ariza A
J Cell Mol Med; 2019 Dec; 23(12):8219-8232. PubMed ID: 31560832
[TBL] [Abstract][Full Text] [Related]
59. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
[TBL] [Abstract][Full Text] [Related]
60. An overview of esophageal squamous cell carcinoma proteomics.
Qi YJ; Chao WX; Chiu JF
J Proteomics; 2012 Jun; 75(11):3129-37. PubMed ID: 22564818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
